Recommended Vaccine Shots for Adults Without Medical Conditions
All healthy adults should receive annual influenza vaccination, Tdap (one-time replacement for Td booster), and age-specific vaccines including HPV (through age 26 for women, age 21 for men), pneumococcal vaccines (starting at age 50), and herpes zoster vaccine (starting at age 50-60 years). 1, 2, 3
Core Vaccines for All Adults
Influenza Vaccine
- Annual influenza vaccination is recommended for all adults aged ≥19 years regardless of health status. 1, 4
- The 2024-2025 COVID-19 vaccine provides 33% effectiveness against ED/UC visits and 45-46% effectiveness against hospitalization in adults, supporting annual COVID-19 vaccination as well. 5
Tetanus, Diphtheria, and Pertussis (Td/Tdap)
- Administer one dose of Tdap to replace a single Td booster for all adults who have not previously received Tdap. 1, 4
- Continue Td boosters every 10 years after the Tdap dose. 1, 4
- For adults with unknown vaccination history, complete a 3-dose primary series with doses at 0,4 weeks, and 6-12 months, substituting Tdap for one dose. 4
Age-Based Vaccines
Human Papillomavirus (HPV)
- Women through age 26 years: 3-dose series (0,2, and 6 months). 1, 4
- Men through age 21 years: 3-dose series. 1
- Vaccination is recommended even for sexually active individuals, as they may not have been infected with all vaccine HPV types. 4
Pneumococcal Vaccines
- Adults aged ≥50 years: Single dose of PCV20 (preferred) or PCV15 followed by PPSV23. 2, 3
- For those choosing PCV15, administer PPSV23 at least 1 year later. 2
- The 2024 ACIP recommendation expanded age-based pneumococcal vaccination from age 65 to age 50 years. 3
Herpes Zoster (Shingles) Vaccine
- Adults aged ≥50 years: Recombinant zoster vaccine (Shingrix) is recommended regardless of prior chickenpox history. 6, 1
- A single dose of zoster vaccine was previously recommended at age ≥60 years, but newer guidelines favor Shingrix starting at age 50. 1, 4
- The recombinant vaccine (Shingrix) is preferred over the live vaccine (Zostavax) for all eligible adults. 6
Measles, Mumps, Rubella (MMR)
- Adults born during or after 1957 should receive ≥1 dose of MMR unless they have documentation of vaccination, laboratory evidence of immunity, or provider-diagnosed disease history. 4
- Adults born before 1957 can generally be considered immune. 4
- A second dose is recommended for healthcare workers, students in postsecondary institutions, and international travelers. 4
Varicella (Chickenpox)
- All adults without evidence of immunity should receive 2 doses of varicella vaccine, 4-8 weeks apart. 4
- Evidence of immunity includes: documentation of 2 vaccine doses, U.S. birth before 1980 (except healthcare workers), provider-diagnosed varicella or herpes zoster history, or laboratory evidence. 4
- Special consideration for teachers, childcare employees, college students, military personnel, healthcare workers, and international travelers. 4
Hepatitis Vaccines (Risk-Based, but Consider for All)
Hepatitis A
- Standard schedule: 2 doses at 0 and 6-12 months (Havrix) or 0 and 6-18 months (Vaqta). 2, 4
- Recommended for travelers to endemic areas, men who have sex with men, injection drug users, and anyone desiring immunity. 1, 4
Hepatitis B
- 3-dose series at 0,1, and 6 months for adults without prior vaccination. 1
- Particularly important for healthcare workers, sexually active persons not in monogamous relationships, and men who have sex with men. 1
Common Pitfalls to Avoid
- Do not assume birth before 1957 confers immunity for healthcare workers—they require documented MMR vaccination or laboratory evidence. 4
- Do not delay Tdap waiting for the 10-year Td interval—Tdap can be given as early as 2 years after the last Td dose. 4
- Do not confuse the live zoster vaccine (Zostavax) with recombinant vaccine (Shingrix)—Shingrix is now preferred and can be given to those without chickenpox history. 6
- Do not forget that HPV vaccination benefits even sexually active individuals—they may not have been exposed to all vaccine types. 4
Vaccination Coverage and Access
Despite these recommendations, adult vaccination coverage remains suboptimal, with only 44.8% receiving influenza vaccine and 30.6% of adults ≥60 years receiving herpes zoster vaccine in 2015. 7 Adults with health insurance, a usual healthcare provider, and regular physician visits have significantly higher vaccination rates. 7